32.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
Is Viking Therapeutics the Next Big Biotech Bet? - AOL.com
Better Growth Buy: Eli Lilly vs. Viking Therapeutics - AOL.com
What makes Viking Therapeutics Inc. stock price move sharplyTop Growth Tracker With Low Risk - jammulinksnews.com
Viking Bets Big On Obesity And NASH With Dual-Agonist Pipeline - Finimize
Is it the right time to buy Viking Therapeutics Inc. stockEarnings Report Alerts With Proven Results - jammulinksnews.com
Viking Therapeutics, Inc. (VKTX) Nears Obesity Drug Breakthrough with Phase 3 VK2735 Trial - MSN
Axsome Therapeutics and Viking Therapeutics: Biotech Stocks to WatchNews and Statistics - IndexBox
Wall Street Predicts Axsome Therapeutics and Viking Therapeutics Stocks to Soar 74% to 159% - AInvest
Why Viking Therapeutics Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - metal.it
Sentiment Turns Positive on Viking Therapeutics Inc. — Reversal AheadMarket Entry and Exit Point Tips From Traders - metal.it
What is the dividend policy of Viking Therapeutics Inc. stockBeginner Investor Insights That Work - jammulinksnews.com
How does Viking Therapeutics Inc. compare to its industry peersDynamic investment growth - jammulinksnews.com
Raymond James Financial Issues Pessimistic Forecast for Viking Therapeutics (NASDAQ:VKTX) Stock Price - MarketBeat
Why is Viking Therapeutics Inc. stock attracting strong analyst attentionTriple returns potential - jammulinksnews.com
What catalysts could drive Viking Therapeutics Inc. stock higher in 2025Rapid market gains - jammulinksnews.com
What are the technical indicators suggesting about Viking Therapeutics Inc.Unlock steady growth with low-risk stocks - jammulinksnews.com
Is Viking Therapeutics Inc. stock overvalued or undervaluedAI Powered Tips For 2025 - jammulinksnews.com
Viking Therapeutics’ Earnings Call: Clinical Advances Amid Financial Challenges - TipRanks
What institutional investors are buying Viking Therapeutics Inc. stockBuild wealth with reliable stock picks - jammulinksnews.com
What are analysts’ price targets for Viking Therapeutics Inc. in the next 12 monthsRecord-setting profit potential - jammulinksnews.com
When is Viking Therapeutics Inc. stock expected to show significant growthTremendous growth potential - jammulinksnews.com
Viking Therapeutics Stock Soars Amid Clinical Progress - TipRanks
Viking Therapeutics EPS miss sends shares down 7% - MSN
Viking Therapeutics Inc. Stock Analysis and ForecastUnmatched market gains - PrintWeekIndia
Behind the Scenes of Viking Therapeutics's Latest Options Trends - Benzinga
VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales - MSN
Is Viking Therapeutics Inc. a good long term investmentPhenomenal investment performance - PrintWeekIndia
H.C. Wainwright Reiterates a Buy Rating on Viking Therapeutics (VKTX), Sets a $102 PT - MSN
Viking Therapeutics Q2: Confidently Continuing The Recovery (NASDAQ:VKTX) - Seeking Alpha
Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Viking Therapeutics (VKTX) - The Globe and Mail
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2025 Earnings Call Transcript - Insider Monkey
Truist Financial Sticks to Their Buy Rating for Viking Therapeutics (VKTX) - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Viking Therapeutics (VKTX), Opus Genetics (IRD) - The Globe and Mail
Viking Therapeutics Receives Buy Rating Amid Promising Clinical Developments and Strategic Initiatives - TipRanks
What drives Viking Therapeutics Inc. stock priceAccelerated wealth expansion - PrintWeekIndia
Viking Therapeutics stock maintains Buy rating at Stifel on obesity drug potential - Investing.com
Viking Therapeutics Surges to 433rd in Trading Volume as Strategic Partnership and Clinical Success Fuel Stock Rally - AInvest
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):